𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Expression and significance of urokinase type plasminogen activator gene in human brain gliomas

✍ Scribed by Xiang Zhang; Zhou Fei; Xing-yao Bu; Hai-ning Zhen; Zhi-wen Zhang; Jian-wen Gu; Yi-jun Chen


Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
164 KB
Volume
74
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

✦ Synopsis


Background and objectives:

Urokinase type plasminogen activator (upa) regulates a variety of processes involved in tissue morphogenesis, cell differentiation, migration and invasion. we analyzed the available informations to better interpret the pathogenetic relationship between upa activity and the malignant biological behavior of human brain gliomas.

Methods:

We retrospectively studied the presence and distribution of upa in human brain gliomas by northern blot hybridization and immunohistochemical methods in 43 cases of brain gliomas and 5 cases of normal brain tissues.

Results:

All tissues expressed 2.5 kb transcripts of upa mrna. the upa mrna levels were significantly higher in high-grade gliomas than in low-grade gliomas and normal brain tissues (p < 0.01). levels of upa mrna expression in tumor tissues with recurrence in 18 months postoperatively and survival period less than 3 years were significantly higher than counterparts (p < 0.01). the distribution of upa protein in the immunoreactivity was mainly in tumor cells and microvascular endothelial cells of glioblastomas and anaplastic astrocytomas, localizing at cytoplasms, especially near sites of vascular proliferation and at the leading edges of tumors.

Conclusions:

High expression of upa gene is associated with the malignant progression of gliomas and demonstrates a high level of correlation with the recurrence and invasive behaviors of high grade gliomas.


πŸ“œ SIMILAR VOLUMES


Expression and cellular localization of
✍ Dubuisson, L.; Monvoisin, A.; Nielsen, B. S.; Le Bail, B.; Bioulac-Sage, P.; Ros πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 437 KB

The urokinase-type plasminogen activator (uPA) and its receptor (uPAR) play an important role in tumour invasion. Previous studies have shown by RT-PCR that uPA and uPAR mRNAs are expressed in human hepatocellular carcinoma (HCC). Here, in situ hybridization, immunohistochemistry, and double immunoΒ―

Expression ofMet protein and urokinase-t
✍ Zanetti, Antonio; Stoppacciaro, Antonella; Marzullo, Antonella; Ciabatta, Maria; πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 314 KB

Met protein encoded by MET oncogene is the high affinity receptor for hepatocyte growth factor (HGF)/scatter factor (SF). HGF/SF has to be cleaved in its heterodimeric form by the urokinase-type plasminogen activator (uPA) to become active as a ligand for Met receptor. The expression of Met protein

Prognostic impact of stromal cell-derive
✍ Yasushi Okusa; Takashi Ichikura; Hidetaka Mochizuki πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 99 KB πŸ‘ 1 views

## Background: Urokinase-type plasminogen activator (upa) plays an important role in the destruction of the extracellular matrix and basement membrane around cancer cells. in the current study, the authors investigated upa expression in cancer cells and stromal cells in patients with gastric carcin

Co-expression of urokinase-type plasmino
✍ Il-Kyoo Park; Bum-Joon Kim; Young-Joo Goh; Mi-Ae Lyu; Chung-Gyu Park; Eung-Soo H πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 205 KB

The expression of urokinase-type plasminogen activator (u-PA), its receptor (u-PAR) and metalloproteases activity were analyzed in 4 human gastric-cancer cell lines (AGS, Hs746T, SNU-1, and SNU-5), in an attempt to relate these activities to their invasive potential and tumorigenicity on the modifie

Association of tagSNPs in the urokinase-
✍ Ayla Ozturk; Ryan L. Minster; Steven T. DeKosky; M. Ilyas Kamboh πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 66 KB πŸ‘ 1 views

## Abstract The gene coding for urokinase‐plasminogen activator (PLAU) is a strong biological and positional candidate gene for Alzheimer's disease (AD). Previously some studies have examined the role of common variation in the PLAU gene with AD risk but the results have been inconsistent and this